Prostate Cancer - Results from #19660

Association of androgen deprivation therapy with excess cardiac-specific mortality in men with prostate cancer - Abstract September 24, 2014

Multiparametric MRI in biopsy guidance for prostate cancer: Fusion-guided - Abstract September 24, 2014

Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer - Abstract September 24, 2014

Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: Outcomes of 1300 patients - Abstract September 24, 2014

A framework to evaluate the cost-effectiveness of the NADiA ProsVue slope to guide adjuvant radiotherapy among men with high-risk characteristics following prostatectomy for prostate cancer - Abstract September 24, 2014

Physician social networks and variation in rates of complications after radical prostatectomy - Abstract September 23, 2014

Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy - Abstract September 23, 2014

Getting Black men to undergo prostate cancer screening: The role of social capital - Abstract September 23, 2014

Phase-1 study of abiraterone acetate in chemotherapy-naïve Japanese patients with castration-resistant prostate cancer - Abstract September 23, 2014

A new 5-grading score in the diagnosis of prostate cancer with real-time elastography - Abstract September 23, 2014

Robotic radical prostatectomy in patients with previous prostate surgery and radiotherapy - Abstract September 23, 2014

New acquisition protocol of (18) F-choline PET/CT in prostate cancer patients: Review of the literature about methodology and proposal of standardization - Abstract September 22, 2014

Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone - Abstract September 22, 2014

Predictive clinical indicators of biochemical progression in advanced prostate cancer patients receiving leuplin depot as androgen deprivation therapy - Abstract September 22, 2014

An investigation of the support needs of men and partners throughout the prostate cancer journey - Abstract September 22, 2014

Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer - Abstract September 22, 2014

Pathologic fracture in patients with metastatic prostate cancer - Abstract September 16, 2014

Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients - Abstract September 16, 2014

Significance of image guidance to clinical outcomes for localized prostate cancer - Abstract September 16, 2014

Ethnicity is an independent determinant of age-specific PSA level: Findings from a multiethnic Asian setting - Abstract September 16, 2014

Page 984 of 1436